Efficacy and Safety of Crisaborole Ointment 2% in Chinese Patients Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis

Abstract Introduction Atopic dermatitis (AD) is a chronic immuno-inflammatory skin disease. Crisaborole ointment, 2%, is a nonsteroidal phosphodiesterase 4 inhibitor approved for the treatment of mild to moderate AD. This post hoc analysis assesses the efficacy and safety of crisaborole in Chinese p...

Cijeli opis

Bibliografski detalji

Glavni autori:	Lin Ma, Xiaohua Tao, Sujun Liu, Hao Cheng, Ruihua Fang, Yan Zhao, Amy Cha, Gerardo A. Encinas, Yangmei Zhou, Yujie Deng, Jianzhong Zhang
Format:	Artigo
Jezik:	Inglês
Izdano:	Adis, Springer Healthcare 2024-05-01
Serija:	Dermatology and Therapy
Teme:	Atopic dermatitis Chinese patients Crisaborole Eczema Area and Severity Index Infant Phosphodiesterase 4 inhibitors
Online pristup:	https://doi.org/10.1007/s13555-024-01156-6
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!